Konduri Praneeta, Bucker Amber, Boers Anna, Dutra Bruna, Samuels Noor, Treurniet Kilian, Berkhemer Olvert, Yoo Albert, van Zwam Wim, van Oostenbrugge Robert, van der Lugt Aad, Dippel Diederik, Roos Yvo, Bot Joost, Majoie Charles, Marquering Henk
Department of Biomedical Engineering and Physics, Amsterdam UMC, Location AMC, Amsterdam, Netherlands.
Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC, Amsterdam, Netherlands.
Front Neurol. 2022 Oct 5;13:977608. doi: 10.3389/fneur.2022.977608. eCollection 2022.
Even days after treatment of acute ischemic stroke due to a large vessel occlusion, the infarct lesion continues to grow. This late, subacute growth is associated with unfavorable functional outcome. In this study, we aim to identify patient characteristics that are risk factors of late, subacute lesion growth.
Patients from the MR CLEAN trial cohort with good quality 24 h and 1-week follow up non-contrast CT scans were included. Late Lesion growth was defined as the difference between the ischemic lesion volume assessed after 1-week and 24-h. To identify risk factors, patient characteristics associated with lesion growth (categorized in quartiles) in univariable ordinal analysis ( < 0.1) were included in a multivariable ordinal regression model.
In the 226 patients that were included, the median lesion growth was 22 (IQR 10-45) ml. In the multivariable model, lower collateral capacity [aOR: 0.62 (95% CI: 0.44-0.87); = 0.01], longer time to treatment [aOR: 1.04 (1-1.08); = 0.04], unsuccessful recanalization [aOR: 0.57 (95% CI: 0.34-0.97); = 0.04], and larger midline shift [aOR: 1.18 (95% CI: 1.02-1.36); = 0.02] were associated with late lesion growth.
Late, subacute, lesion growth occurring between 1 day and 1 week after ischemic stroke treatment is influenced by lower collateral capacity, longer time to treatment, unsuccessful recanalization, and larger midline shift. Notably, these risk factors are similar to the risk factors of acute lesion growth, suggesting that understanding and minimizing the effects of the predictors for late lesion growth could be beneficial to mitigate the effects of ischemia.
即使在因大血管闭塞导致的急性缺血性卒中治疗数天后,梗死灶仍会继续增大。这种晚期的亚急性生长与不良功能预后相关。在本研究中,我们旨在确定作为晚期亚急性病灶生长危险因素的患者特征。
纳入来自MR CLEAN试验队列且有高质量24小时和1周随访非增强CT扫描的患者。晚期病灶生长定义为1周后评估的缺血病灶体积与24小时后评估的缺血病灶体积之差。为了确定危险因素,单变量有序分析(<0.1)中与病灶生长相关的患者特征(按四分位数分类)被纳入多变量有序回归模型。
在纳入的226例患者中,病灶生长的中位数为22(IQR 10 - 45)ml。在多变量模型中,较低的侧支循环能力[aOR:0.62(95%CI:0.44 - 0.87);P = 0.01]、较长的治疗时间[aOR:1.04(1 - 1.08);P = 0.04]、再通失败[aOR:0.57(95%CI:0.34 - 0.97);P = 0.04]以及较大的中线移位[aOR:1.18(95%CI:1.02 - 1.36);P = 0.02]与晚期病灶生长相关。
缺血性卒中治疗后1天至1周内发生的晚期亚急性病灶生长受侧支循环能力较低、治疗时间较长、再通失败和中线移位较大的影响。值得注意的是,这些危险因素与急性病灶生长的危险因素相似,这表明了解并尽量减少晚期病灶生长预测因素的影响可能有助于减轻缺血的影响。